Literature DB >> 3856884

Suppression of tumorigenicity in hybrids of normal and oncogene-transformed CHEF cells.

R W Craig, R Sager.   

Abstract

Somatic cell hybridization experiments were carried out to determine whether normal cells have the ability to suppress the transforming effects of a defined oncogene. A nontransformed Chinese hamster embryo fibroblast cell line (CHEF/18-dm2) was used as the normal parent, and a CHEF/18 transfectant carrying the human mutant c-Ha-ras (EJ) oncogene was used as the tumorigenic parent. Selected hybrids (L318 cell lines) were assayed for the presence of EJ DNA, for the p21 product of the c-Ha-ras gene, and for various indices of cell transformation. These hybrids exhibited a fibroblastic morphology similar to the normal parent, although they contained the EJ gene and expressed its p21 protein product at levels comparable with the transformed parent. They had a reduced capacity for anchorage-independent growth (plating efficiency in methylcellulose of less than 0.3-13%, as compared with greater than 90% for the transformed parent) and decreased tumor-forming ability in athymic mice. These findings show that normal CHEF/18 cells contain suppressor genes capable of inhibiting expression of the transformed phenotype, and tumor-forming ability, in the presence of an activated EJ oncogene.

Entities:  

Mesh:

Year:  1985        PMID: 3856884      PMCID: PMC397492          DOI: 10.1073/pnas.82.7.2062

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  Noncoordinate expression of SV40-induced transformation and tumorigenicity in mouse cell hybrids.

Authors:  N Howell; R Sager
Journal:  Somatic Cell Genet       Date:  1979-01

2.  Genetic analysis of tumorigenesis: XXI. Suppressor genes in CHEF cells.

Authors:  B L Smith; R Sager
Journal:  Somat Cell Mol Genet       Date:  1985-01

3.  Genomic rearrangements in a mouse cell line containing integrated SV40 DNA.

Authors:  R Sager; A Anisowicz; N Howell
Journal:  Cell       Date:  1981-01       Impact factor: 41.582

4.  Regulated transcription of c-Ki-ras and c-myc during compensatory growth of rat liver.

Authors:  M Goyette; C J Petropoulos; P R Shank; N Fausto
Journal:  Mol Cell Biol       Date:  1984-08       Impact factor: 4.272

5.  Genetic analysis of tumorigenesis: IV. Chromosome reduction and marker segregation in progeny clones from Chinese hamster cell hybrids.

Authors:  R Sager; P E Kovac
Journal:  Somatic Cell Genet       Date:  1979-07

6.  Transformation of NIH 3T3 cells by microinjection of Ha-ras p21 protein.

Authors:  D W Stacey; H F Kung
Journal:  Nature       Date:  1984 Aug 9-15       Impact factor: 49.962

7.  Genetic analysis of tumorigenesis: I. Expression of tumor-forming ability in hamster hybrid cell lines.

Authors:  R Sager; P E Kovac
Journal:  Somatic Cell Genet       Date:  1978-05

8.  Human cell hybrids: analysis of transformation and tumorigenicity.

Authors:  E J Stanbridge; C J Der; C J Doersen; R Y Nishimi; D M Peehl; B E Weissman; J E Wilkinson
Journal:  Science       Date:  1982-01-15       Impact factor: 47.728

9.  Selection for animal cells that express the Escherichia coli gene coding for xanthine-guanine phosphoribosyltransferase.

Authors:  R C Mulligan; P Berg
Journal:  Proc Natl Acad Sci U S A       Date:  1981-04       Impact factor: 11.205

10.  Transforming activity of human tumor DNAs.

Authors:  T G Krontiris; G M Cooper
Journal:  Proc Natl Acad Sci U S A       Date:  1981-02       Impact factor: 11.205

View more
  24 in total

1.  A growth arrest-specific (gas) gene codes for a membrane protein.

Authors:  G Manfioletti; M E Ruaro; G Del Sal; L Philipson; C Schneider
Journal:  Mol Cell Biol       Date:  1990-06       Impact factor: 4.272

2.  Interferon-induced revertants of ras-transformed cells: resistance to transformation by specific oncogenes and retransformation by 5-azacytidine.

Authors:  D Samid; D M Flessate; R M Friedman
Journal:  Mol Cell Biol       Date:  1987-06       Impact factor: 4.272

3.  Down regulation by p60v-src of genes specifically expressed and developmentally regulated in postmitotic quail neuroretina cells.

Authors:  M Guermah; G Gillet; D Michel; D Laugier; G Brun; G Calothy
Journal:  Mol Cell Biol       Date:  1990-07       Impact factor: 4.272

4.  Loss of tumor-suppressive function during chemically induced neoplastic progression of Syrian hamster embryo cells.

Authors:  M Koi; J C Barrett
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

5.  A recessive cellular mutation in v-fes-transformed mink cells restores contact inhibition and anchorage-dependent growth.

Authors:  J R Haynes; J R Downing
Journal:  Mol Cell Biol       Date:  1988-06       Impact factor: 4.272

6.  Mitogenic effects of the proto-oncogene and oncogene forms of c-H-ras DNA in human diploid fibroblasts.

Authors:  C K Lumpkin; J E Knepper; J S Butel; J R Smith; O M Pereira-Smith
Journal:  Mol Cell Biol       Date:  1986-08       Impact factor: 4.272

7.  Plasmid-induced "hit-and-run" tumorigenesis in Chinese hamster embryo fibroblast (CHEF) cells.

Authors:  C C Lau; I K Gadi; S Kalvonjian; A Anisowicz; R Sager
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

8.  Coinfection with viruses carrying the v-Ha-ras and v-myc oncogenes leads to growth factor independence by an indirect mechanism.

Authors:  M Vogt; J Lesley; J Bogenberger; S Volkman; M Haas
Journal:  Mol Cell Biol       Date:  1986-10       Impact factor: 4.272

9.  Tumor suppression involves down-regulation of interleukin 3 expression in hybrids between autocrine mastocytoma and interleukin 3-dependent parental mast cells.

Authors:  I D Diamantis; A P Nair; H H Hirsch; C Moroni
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

10.  Suppression of tumorigenicity with continued expression of the c-Ha-ras oncogene in EJ bladder carcinoma-human fibroblast hybrid cells.

Authors:  A G Geiser; C J Der; C J Marshall; E J Stanbridge
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.